The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re CVA

12 Sep 2023 08:45

RNS Number : 1540M
Iconic Labs PLC
12 September 2023
 

 

 

 12 September 2023

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Allotment of Shares and Conclusion of CVA

 

Iconic Labs PLC (LSE: ICON) today announces that 83,256 ordinary shares of £0.1 were allotted to the unsecured creditors (the "Unsecured Creditors") in accordance with the Creditors Voluntary Arrangement (CVA) dated 22 September 2022.

 

Application is being made for 83,256 new Ordinary Shares to be admitted to trading on the Main Market of the London Stock Exchange which is expected to be on or around 15 September 2023. These shares rank pari passu with the existing Ordinary Shares of the Company.

 

Following the issue of these shares, the Company's issued ordinary share capital shall consist of 5,003,275 Ordinary Shares. The figure of 5,003,275 represents the total voting rights in the Company and should be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance & Transparency Rules.

 

Brad Taylor, Chief Executive Officer of Iconic Labs, commented:

 

"We are pleased to announce the allotment of shares to the Unsecured Creditors satisfies the final condition to bring the CVA to a successful conclusion. Once the CVA is discharged, Iconic will be well positioned to focus on its business goals. The Board remains committed to delivering value to our shareholders and stakeholders alike."

 

- Ends -

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For any further information or enquiries please contact:

 

Iconic Labs

Brad Taylor, Chief Executive Officer

Tel: +44 (0) 7462 156238

ir@iconiclabs.co.uk

Novum Securities Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7399 9400

 

Yellow Jersey PR

Sarah Hollins

Annabelle Wills

Bessie Elliot

 

Tel: +44 (0) 20 3004 9512

iconic@yellowjerseypr.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUUSBRORUKARR
Date   Source Headline
19th May 20214:00 pmRNSDirectorate Change
10th May 202111:05 amRNSSecond Price Monitoring Extn
10th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:05 amRNSSecond Price Monitoring Extn
10th May 20219:00 amRNSPrice Monitoring Extension
10th May 20218:12 amRNSLetter of Intent Signed : Sting Industries
4th May 20214:41 pmRNSSecond Price Monitoring Extn
4th May 20214:36 pmRNSPrice Monitoring Extension
4th May 20212:06 pmRNSSecond Price Monitoring Extn
4th May 20212:01 pmRNSPrice Monitoring Extension
30th Apr 20214:41 pmRNSSecond Price Monitoring Extn
30th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20212:17 pmRNSHalf-year Report
29th Apr 20217:52 amRNSDirectorate Change
23rd Apr 202111:05 amRNSSecond Price Monitoring Extn
23rd Apr 202111:00 amRNSPrice Monitoring Extension
21st Apr 20214:35 pmRNSPrice Monitoring Extension
19th Apr 20212:06 pmRNSSecond Price Monitoring Extn
19th Apr 20212:01 pmRNSPrice Monitoring Extension
16th Apr 202111:06 amRNSSecond Price Monitoring Extn
16th Apr 202111:00 amRNSPrice Monitoring Extension
16th Apr 20219:03 amRNSEHGOF withdraws its claims
14th Apr 20217:00 amRNSStatement re Dispute with Greencastle
1st Apr 202111:00 amRNSPrice Monitoring Extension
26th Mar 20214:40 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
26th Mar 20214:01 pmRNSAgreement
26th Mar 20217:00 amRNSDirectorate Change
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSDirectorate Change
22nd Mar 20212:06 pmRNSSecond Price Monitoring Extn
22nd Mar 20212:01 pmRNSPrice Monitoring Extension
19th Mar 20217:00 amRNSDirectorate Change
8th Mar 20214:41 pmRNSSecond Price Monitoring Extn
8th Mar 20214:36 pmRNSPrice Monitoring Extension
5th Mar 20219:05 amRNSSecond Price Monitoring Extn
5th Mar 20219:00 amRNSPrice Monitoring Extension
3rd Mar 20212:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20212:00 pmRNSPrice Monitoring Extension
3rd Mar 202110:50 amRNSDirectorate Change
19th Feb 202111:00 amRNSPrice Monitoring Extension
12th Feb 20213:13 pmRNSDirectorate Change
9th Feb 20217:00 amRNSDirectorate Change
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
5th Feb 202111:06 amRNSSecond Price Monitoring Extn
5th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20219:05 amRNSSecond Price Monitoring Extn
5th Feb 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.